mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.3 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |